Document Detail


Netilmicin use in pediatric patients.
MedLine Citation:
PMID:  7438970     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
40 newborn infants and children were treated with netilmicin. With a 2-mg/kg dose, the average peak serum concentration was 4.4 microgram/ml. Serum concentrations resulting from the first dose were markedly lower than subsequent doses and therapeutically inadequate. Significant drug accumulation did not occur: peak and trough concentrations on days 2 and 7 were the same in patients with normal renal function. The half-life of netilmicin in infants less than 1 week old was 3.8 h in infants older than 1 week. Infants less than 7 days old require a prolonged dose interval (12 h) to adequately clear the administered dose. Recovery of netilmicin in urine ranged from 50 to 100% and correlated with age and duration of treatment. Elimination of netilmicin was prolonged in newborn infants with renal failure and requires dosage adjustment. Transient change in creatinine clearance occurred in 2 patients (4.6%) and ototoxicity was observed on 2 other patients.
Authors:
V Chindasilpa; V Schauf; L R Hamilton; L J Riff
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Developmental pharmacology and therapeutics     Volume:  1     ISSN:  0379-8305     ISO Abbreviation:  Dev Pharmacol Ther     Publication Date:  1980  
Date Detail:
Created Date:  1981-02-19     Completed Date:  1981-02-19     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8003947     Medline TA:  Dev Pharmacol Ther     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  238-53     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Bacteria / drug effects
Bacterial Infections / drug therapy*
Child
Gentamicins / therapeutic use*
Half-Life
Hearing / drug effects
Humans
Infant
Infant, Newborn
Infant, Newborn, Diseases / drug therapy
Netilmicin / metabolism,  therapeutic use*,  toxicity
Chemical
Reg. No./Substance:
0/Gentamicins; 56391-56-1/Netilmicin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of indomethacin on desoxycorticosterone acetate-sodium chloride-induced renal lesions in the ...
Next Document:  Recurrent febrile lymphadenopathy treated with large doses of vitamin B1: report of two cases.